Squarepoint’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,890
| Closed | -$79.7K | – | 3098 |
|
|
2024
Q1 | $79.7K | Buy |
+14,890
| New | +$79.7K | ﹤0.01% | 2280 |
|
|
2021
Q2 | – | Sell |
-7,573
| Closed | -$566K | – | 3118 |
|
|
2021
Q1 | $566K | Buy |
7,573
+4,627
| +157% | +$346K | ﹤0.01% | 1448 |
|
|
2020
Q4 | $320K | Buy |
2,946
+1,735
| +143% | +$188K | ﹤0.01% | 1820 |
|
|
2020
Q3 | $107K | Buy |
+1,211
| New | +$107K | ﹤0.01% | 2114 |
|
|
2020
Q2 | – | Sell |
-1,151
| Closed | -$68K | – | 2494 |
|
|
2020
Q1 | $68K | Sell |
1,151
-3,349
| -74% | -$198K | ﹤0.01% | 1690 |
|
|
2019
Q4 | $311K | Buy |
+4,500
| New | +$311K | ﹤0.01% | 1952 |
|